ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Inhibition of TLR4/TRAF6/NF-κB pathway by empagliflozin mitigates concanavalin A-induced autoimmune hepatitis in mice.

Dalia H El-Kashef et al.PubMed ↗Publisher ↗

No numbers read from the abstract.